HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

indolepropionic acid

structure in third source

Also Known As:

indole propionate; indole-3-propanoic acid; 1H-indole-3-proponoic acid

Networked: 7 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indoles: 200
      - indolepropionic acid: 7

Experts

1.	Bai, Péter: 2 articles (10/2020 - 08/2020)
2.	Boratkó, Anita: 2 articles (10/2020 - 08/2020)
3.	Jankó, Laura: 2 articles (10/2020 - 08/2020)
4.	Kiss, Borbála: 2 articles (10/2020 - 08/2020)
5.	Kovács, Tünde: 2 articles (10/2020 - 08/2020)
6.	Mikó, Edit: 2 articles (10/2020 - 08/2020)
7.	Sári, Zsanett: 2 articles (10/2020 - 08/2020)
8.	Ujlaki, Gyula: 2 articles (10/2020 - 08/2020)
9.	Auriola, Seppo: 2 articles (01/2018 - 11/2017)
10.	Hanhineva, Kati: 2 articles (01/2018 - 11/2017)

Related Diseases

1.	Type 2 Diabetes Mellitus (MODY) 01/01/2018 - "Associations of serum indolepropionic acid, a gut microbiota metabolite, with type 2 diabetes and low-grade inflammation in high-risk individuals." 11/01/2017 - "Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the Finnish Diabetes Prevention Study." 01/01/2018 - "We recently reported using non-targeted metabolic profiling that serum indolepropionic acid (IPA), a microbial metabolite of tryptophan, was associated with a lower likelihood of developing type 2 diabetes (T2D). " 10/01/2022 - "Previous studies have indicated that indolepropionic acid (IPA), derived from dietary tryptophan via gut microbiota conversion, is negatively correlated with type 2 diabetes mellitus and systemic low-grade inflammation. " 11/06/2022 - "One of the tryptophan derivatives, indolepropionic acid (IPA), is increasingly being studied as a marker for the onset and development of metabolic disorders, including type 2 diabetes (T2D) and non-alcoholic fatty liver disease (NAFLD). "
2.	Inflammation (Inflammations) 01/01/2018 - "Associations of serum indolepropionic acid, a gut microbiota metabolite, with type 2 diabetes and low-grade inflammation in high-risk individuals." 10/01/2022 - "Previous studies have indicated that indolepropionic acid (IPA), derived from dietary tryptophan via gut microbiota conversion, is negatively correlated with type 2 diabetes mellitus and systemic low-grade inflammation. "
3.	Breast Neoplasms (Breast Cancer) 08/25/2020 - "Indolepropionic Acid, a Metabolite of the Microbiome, Has Cytostatic Properties in Breast Cancer by Activating AHR and PXR Receptors and Inducing Oxidative Stress." 10/10/2020 - "Taken together, IS, similar to indolepropionic acid (another tryptophan metabolite), has cytostatic properties and higher expression of the metabolic machinery responsible for the formation of IS supports survival in breast cancer."
4.	Non-alcoholic Fatty Liver Disease 11/06/2022 - "One of the tryptophan derivatives, indolepropionic acid (IPA), is increasingly being studied as a marker for the onset and development of metabolic disorders, including type 2 diabetes (T2D) and non-alcoholic fatty liver disease (NAFLD). " 11/06/2022 - "Indolepropionic Acid, a Gut Bacteria-Produced Tryptophan Metabolite and the Risk of Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease."
5.	Reperfusion Injury 12/01/2002 - "Amelioration of hepatic ischemia/reperfusion injury using indolepropionic acid."

Related Drugs and Biologics

1.	Tryptophan (L-Tryptophan)
2.	Lipids
3.	Cytostatic Agents